Presumably somatic DDX41 variants occur in approximately 2.4% of all MDS patients (16) and less than 1% of AML patients (45–47), strengthening the assumption that the majority of identified DDX41 variants may indeed be germline. This evidence concerns the gene DDX41 and myelodysplastic syndrome.